Vector-borne diseases (VBDs) are a significant public health concern in India, contributing to substantial morbidity and mortality. This article provides a comprehensive review of the prevalence and management of VBDs in India, focusing on diseases such as malaria, dengue, and chikungunya.
India, with its diverse ecosystems, is a hotspot for VBDs. Malaria remains the most prevalent, with an estimated 5.6 million cases in 2017. Dengue, with an increasing trend, reported approximately 188,401 cases in 2017. Chikungunya, although less prevalent, showed a significant rise with approximately 60,777 cases in the same year.
The management of VBDs in India faces several challenges. Inadequate surveillance systems, lack of public awareness, and limited resources for vector control are among the prominent issues. Furthermore, climate change and urbanization contribute to the increased risk and spread of these diseases.
India's approach to managing VBDs involves integrated vector management (IVM). This includes measures like insecticide-treated nets (ITNs), indoor residual spraying (IRS), and larviciding. Additionally, early diagnosis and prompt treatment are crucial. Public health education is also emphasized to raise awareness and encourage preventive measures.
Vector-borne diseases continue to pose significant health challenges in India. Understanding their prevalence and effective management strategies is crucial for healthcare professionals. By adopting a multi-pronged approach involving vector control, early diagnosis, treatment, and public education, it is possible to reduce the burden of these diseases significantly.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation